Which federal agency does American Hospital Association comment on most?

American Hospital Association is most active at the Centers for Medicare & Medicaid Services.

← OpenPolis Sign in

American Hospital Association

Unclaimed

Industry

Hospital & Health Care

Staff

440

Chicago, Illinois

Phone

+1 312-422-3000

Website

aha.org

Engagement overview

American Hospital Association has filed 68 public comments across 58 dockets at 18 federal agencies, most actively at the Centers for Medicare & Medicaid Services.

American Hospital Association

Engagement overview

Is this your organization?

Agency footprint

Dockets (58)

Health Data, Technology, and Interoperability: ASTP/ONC Deregulatory Actions To Unleash Prosperity

Request for Information: Accelerating the Adoption and Use of Artificial Intelligence as Part of Clinical Care

Establishing a Fixed Time Period of Admission and an Extension of Stay Procedure for Nonimmigrant Academic Students, Exchange Visitors, and Representatives of Foreign Information Media

NPRM COMMENTS CLOSE ON 12/19/25; PRA COMMENTS CLOSE ON 1/20/26; Public Charge Ground of Inadmissibility

Request for Information Regarding Employee Noncompete Agreements

Weighted Selection Process for Registrants and Petitioners Seeking to File Cap-Subject H-1B Petitions

Request for Public Input on Experiences With FEMA Disaster Responses

Health Data, Technology, and Interoperability: Patient Engagement, Information Sharing, and Public Health Interoperability

Cyber Incident Reporting for Critical Infrastructure Act (CIRCIA) Reporting Requirements

Labor Certification for Permanent Employment of Foreign Workers in the United States; Modernizing Schedule A To Include Consideration of Additional Occupations in Science, Technology, Engineering, and Mathematics (STEM) and Non-STEM Occupations

21st Century Cures Act: Establishment of Disincentives for Health Care Providers That Have Committed Information Blocking

Requirements Related to the Mental Health Parity and Addiction Equity Act

Recently Posted ONCD Rules and Notices.

Cybersecurity Regulatory Harmonization RFI

Draft Merger Guidelines for Public Comment

FTC Seek Comments on the Hart-Scott-Rodino Coverage, Exemption, and Transmittal Rules: Project No. P239300

Section 6417 Elective Payment of Applicable Credits (REG-101607-23)

National Emission Standards for Hazardous Air Pollutants: Commercial Ethylene Oxide Sterilization Technology Review

HIPAA Privacy Rule to Support Reproductive Health Care Privacy

Safeguarding the Rights of Conscience as Protected by Federal Statutes

Non-Compete Clause Rule

Joint Employer 2022

Nondiscrimination in Health Programs and Activities

Solicitation for Public Comments on the Impact of Prescription Benefit Managers’ Business Practices

Affordability of Employer Coverage for Family Members of Employees (REG-114339-21)

COVID-19 Emergency Temporary Standard Rulemaking

Request for Information on Merger Enforcement

Hospital and Health System Compounding Under the Federal Food, Drug, and Cosmetic Act

Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities and Updates to the Value-Based Purchasing Program for Federal Fiscal Year 2021 (CMS-1737-P)

Request for Information: Reducing Administrative Burden to put Patients over Paperwork (CMS-6082-NC)

Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities; Updates to the Quality Reporting Program and Value-Based Purchasing Program for Federal Fiscal Year 2020 (CMS-1718-P)

Inadmissibility on Public Charge Grounds

Identifying the Root Causes of Drug Shortages and Finding Enduring Solutions; Public Meeting; Request for Comments

CY 2019 Hospital Outpatient PPS Policy Changes and Payment Rates and Ambulatory Surgical Center Payment System Policy Changes and Payment Rates CMS-1695-P

Review of Existing Center for Devices and Radiological Health Regulatory and Information Collection Requirements

Review of Existing General Regulatory and Information Collection Requirements of the Food and Drug Administration

Prescription Requirement Under Section 503A of the Federal Food, Drug, and Cosmetic Act

Medicare Program; Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2010

Nondiscrimination in Health Programs and Activities

Memorandum of Understanding Addressing Certain Distributions of Compounded Human Drug Products Between the States and the Food and Drug Administration

Repackaging of Certain Human Drug Products by Pharmacies and Outsourcing Facilities

CY 2016 Notice of Benefit and Payment Parameters CMS-9944-P

Exchange and Insurance Market Standards for 2015 and 2016 CMS-9949-P

CY 2014 Hospital Outpatient PPS Policy Changes and Payment Rates, and CY 2014 Ambulatory Surgical Center Payment System Policy Changes and Payment Rates CMS-1601-P

Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long Term Care Hospital Prospective Payment System and Fiscal Year 2014 Rates; Quality Reporting Requirements for Specific Providers; Hospital Conditions of Participation CMS-1599-P

Food and Drug Administration Drug Shortages Task Force and Strategic Plan; Request for Comments

Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED

Unique Device Identification System

Hospital Outpatient Prospective and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs; Electronic Reporting Pilot; Inpatient Rehabilitation Facilities Quality Reporting Program; Quality Improvement Organization Regulations

FR–5634–N–01 Changes in Certain Multifamily Housing and Health Care Facility Mortgage Insurance Premiums for Fiscal Year (FY) 2013

Applications for Food and Drug Administration Approval to Market a New Drug; Revision of Postmarketing Reporting Requirements--Discontinuance

Establishment of Exchanges and Qualified Health Plans

Prescription Drug User Fee Act

Medicare Program; Accountable Care Organizations and the Medicare Shared Saving Program

Notification of Employee Rights Under Federal Labor Laws

Infectious Substances